throbber
Electrophoresis 2005, 26, 2481–2489
`Quantitative validation of different protein
`precipitation methods in proteome analysis of
`blood platelets
`
`2481
`
`For the preparation of proteins for proteome analysis, precipitation is frequently used
`to concentrate proteins and to remove interfering compounds. Various methods for
`protein precipitation are applied, which rely on different chemical principles. This study
`compares the changes in the protein composition of human blood platelet extracts
`after precipitation with ethanol (EtOH) or trichloroacetic acid (TCA). Both methods
`yielded the same amount of proteins from the platelet preparations. However, the
`EtOH-precipitated samples had to be dialyzed because of the considerable salt con-
`tent. To characterize single platelet proteins, samples were analyzed by two-dimen-
`sional fluorescence differential gel electrophoresis. More than 90% of all the spots
`were equally present in the EtOH- and TCA-precipitated samples. However, both pre-
`cipitation methods showed a smaller correlation with nonprecipitated samples
`(EtOH 74.9%, TCA 79.2%). Several proteins were either reduced or relatively enriched
`in the precipitated samples. The proteins varied randomly in molecular weight and
`isoelectric point. This study shows that protein precipitation leads to specific changes
`in the protein composition of proteomics samples. This depends more on the specific
`structure of the protein than on the precipitating agent used in the experiment.
`
`Keywords: Ethanol / Platelets / Protein precipitation / Proteomics / Trichloroacetic acid
`DOI 10.1002/elps.200410262
`
`Maria Zellner1
`Wolfgang Winkler1
`Hubert Hayden1
`Michael Diestinger1
`Maja Eliasen1
`Bernd Gesslbauer2
`Ingrid Miller3
`Martina Chang4
`Andreas Kungl2
`Erich Roth1
`Rudolf Oehler1
`
`1Surgical Research Laboratories,
`Medical University of Vienna,
`Vienna, Austria
`2Institute of Pharmaceutical
`Sciences,
`University of Graz,
`Graz, Austria
`3Department of Natural Sciences,
`Institute of Medical Chemistry,
`University of Veterinary Medicine,
`Vienna, Austria
`4Institute of Applied Microbiology,
`University of Natural Resources
`and Applied Life Science,
`Vienna, Austria
`
`Proteomicsand2-DE
`
`filtered platelets are more quiescent, and are generally in
`better condition than platelets prepared by multiple
`steps of centrifugation [3]. However, it is impossible to
`concentrate the platelets using this technique. Therefore,
`the protein concentration is low and direct proteomic
`analysis of this platelet isolation is not possible. In addi-
`tion, cells contain proteases and high levels of non-
`protein impurities. An appropriate sample preparation is
`essential for obtaining reliable results in a proteomic
`analysis. Such a preparation should work by inhibiting
`protease activities and quantitatively enriching proteins,
`while leaving behind substances, such as salts, lipids,
`and nucleic acids, which would interfere with any further
`proteomic analysis. Protein precipitation followed by
`dissolving the pellet in IEF compatible sample solution is
`generally employed to concentrate and selectively
`separate proteins in the sample from the interfering sub-
`stances.
`In addition,
`the protein denaturation during
`precipitation leads to an inhibition of proteases [4].
`
`The precipitation of proteins from biological fluids had
`been observed for hundreds of years (e.g., the precipita-
`tion of casein from milk by dilute acid). However, the mo-
`lecular basis of protein solubility began to receive serious
`attention only in the middle of the last century. Fractiona-
`tion of human plasma by precipitation carried forward
`
`1 Introduction
`
`Proteome analysis of clinical samples aims at character-
`izing disease-specific changes in the protein expression
`profile of an affected tissue. Such changes are potential
`diagnostic markers or may help to identify drug targets.
`Blood platelets are small enucleated cellular particles
`that play a fundamental role in hemostasis, contributing
`to the formation of vascular plugs. Pathologically, they
`are involved in thrombosis and atherosclerosis. A
`detailed analysis of the proteome and signaling cas-
`cades in platelets from patients is expected to aid the
`development of new therapeutic agents that may help to
`treat thrombotic diseases [1, 2]. Platelets can be isolated
`from peripheral blood in a few preparative steps to a high
`cellular purity. To prevent activation of platelets,
`it is
`advisable to avoid strong centrifugation and to separate
`platelets from plasma protein by gel filtration. The gel-
`
`Correspondence: Professor Rudolf Oehler, Surgical Research
`Laboratories, General Hospital Vienna, Medical University of
`Vienna, Waehringer Guertel 18–20, A-1090 Vienna, Austria
`E-mail: rudolf.oehler@meduniwien.ac.at
`Fax: 143-1-40400-6782
`
`Abbreviations: DIGE, differential gel electrophoresis; EtOH,
`ethanol; GFP; gel-filtered platelet; PRP, platelet-rich plasma;
`TM3, tropomyosin a 3
`
` 2005 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
`
`Page 1 of 9
`
`YEDA EXHIBIT NO. 2092
`MYLAN PHARM. v YEDA
`IPR2015-00644
`
`

`
`2482
`
`M. Zellner et al.
`
`Electrophoresis 2005, 26, 2481–2489
`
`during World War II made possible the preparation of
`many protein components of the human plasma [5]. The
`solubility of proteins is determined by four variables: pH,
`ionic strength, temperature, and protein concentration.
`Numerous different techniques have been developed for
`protein precipitation by modifying one or more of these
`parameters (for review see [6]). Several methods have
`been adapted to the needs of proteome analysis [4, 7, 8]
`and today various protein extraction kits are commercially
`available which apply precipitation techniques. The pres-
`ent study evaluates the applicability of two methods of
`protein precipitation for clinical proteomics: ethanol
`(EtOH) precipitation and TCA precipitation. Both methods
`are commonly used in the preparation of protein extracts
`for proteomic analysis, although they rely on different
`chemical principles. EtOH causes precipitation of pro-
`teins mainly because it significantly lowers the dielectric
`constant of the aqueous solution (relative dielectric con-
`stant at 207C for H2O is 18 and for C2H5OH is 26). In
`general, ionic compounds are more soluble in solvents
`with high dielectric constants. Through its polar groups,
`EtOH interacts with the polar group of the protein in
`competition with water.
`In addition, the hydrophobic
`groups may disrupt
`the intramolecular hydrophobic
`interaction. Finally, a large volume of EtOH reduces the
`effective concentration of water,
`leaving only a small
`amount for hydration of the protein. Upon dehydration by
`EtOH, protein molecules attract each other to a sufficient
`degree by van der Waals forces and thus become insol-
`uble in the EtOH-water mixtures [9]. TCA, in contrast,
`leads to a strong decrease in pH, resulting in denatura-
`tion and consequently precipitation of the protein. A
`recent study showed that the three chloro groups in the
`molecule also play an important role in protein precipita-
`tion, which is not clear [10]. TFA, which is a stronger acid
`than TCA and possesses three fluoro groups instead of
`chloro groups as in TCA, is not such a potent protein
`precipitation-inducing agent.
`
`The precipitation efficiency of both EtOH and TCA
`depends also on the physicochemical characteristics of
`the protein. Therefore, they are also applied for the frac-
`tionation of protein mixtures. Especially EtOH is broadly
`used for protein fractionation even at industrial scale.
`Proteomics comprises the analysis of thousands of dif-
`ferent protein species simultaneously. Applying EtOH or
`TCA precipitation in the analysis of such complex protein
`mixtures may result in depletion of particular protein spe-
`cies and in a relative enrichment of other protein species.
`The present study investigates qualitative and quantita-
`tive changes in the protein composition of platelet
`extracts after protein precipitation. It describes the pro-
`tein yield, the linearity, and the protein selectivity of EtOH
`and TCA precipitation. By comparing these character-
`
` 2005 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
`
`istics with nonprecipitated samples, the study evaluates
`the suitability of protein precipitation in the proteome
`analysis of clinical samples of this type.
`
`2 Materials and methods
`
`2.1 Blood sampling and platelet preparation
`
`Peripheral venous blood was drawn without stasis from
`60 healthy volunteers aged between 20 and 90 years
`(30 female/30 male; average age 53 6 21 years). The
`study was approved by the local ethics committee. Blood
`was drawn from the antecubital vein of the subjects into
`vacutainer tubes containing 0.129 mol/L trisodium citrate
`(Vacuette system; Greiner, Kremsmuenster, Austria). The
`first 3 mL of blood was discarded as usual for platelet
`studies. For exclusion of erythrocytes and leukocytes, the
`citrated whole blood was centrifuged at 50 3 g for 20 min
`at room temperature. The resulting supernatant was the
`platelet-rich plasma (PRP). A plasma-free platelet sus-
`pension was prepared by passing PRP through a size-
`exclusion chromatography (SEC) column. One milliliter
`PRP was applied onto 11 mL packed Sepharose 2B
`(Sigma, Steinheim, Germany) column (BioRad, Hercules,
`CA, USA; 15 mm diameter) equilibrated in calcium-free
`Dubecco’s PBS (GIBCO, Paisley, Scotland, UK). Platelet
`fractions (1.5 mL) of each individual were collected after
`an elution volume of 2.5 mL, and platelet concentration
`was counted on a MicroDiff 18 Blood Analyzer (Coulter
`Electronics, Miami, FL, USA).
`
`2.2 TCA precipitation
`
`Fifteen-hundred microliters of platelet suspension was
`ice-cold 6.1 N TCA solution
`mixed with 500 mL of
`(Sigma) containing 80 mM DTT (Roche Diagnostics,
`Mannheim, Germany). The mixture was incubated for
`1 h at 47C to allow the protein precipitation to complete.
`Then the extract was centrifuged at 10 000 3 g for
`10 min at 47C. The supernatant was discarded, and the
`pellet was washed four times with 1500 mL of ice-cold
`acetone (p.a. grade; Merck, Darmstadt, Germany) each,
`containing 20 mM DTT; the pellet was regained in each
`step by centrifugation at 10 000 3 g. Thereafter,
`the
`centrifuged pellet was dried by air evacuation. For 2-
`DE, the pellet was resolubilized in denaturing 2-D sam-
`ple buffer containing 7 M urea, 2 M thiourea, 4% CHAPS,
`30 mM Tris-HCl
`(pH 8.5) by shaking overnight at 47C.
`Seventy microliters of the sample buffer was used per
`100 6 106 platelets. Alternatively,
`the samples were
`stored in the last wash aliquot of acetone at 2707C until
`further use.
`
`Page 2 of 9
`
`YEDA EXHIBIT NO. 2092
`MYLAN PHARM. v YEDA
`IPR2015-00644
`
`

`
`Electrophoresis 2005, 26, 2481–2489
`
`Validation of different protein precipitation methods
`
`2483
`
`2.3 EtOH precipitation
`
`Nine-hundred microliters of platelet suspension was
`mixed with 8000 mL EtOH (99.9% Uvasol p.a; Merck).
`Proteins were allowed to precipitate in this EtOH solution
`for 3 h at room temperature followed by storage at 2207C
`overnight. To collect the proteins, the samples were cen-
`trifuged at 10 000 3 g for 20 min at 47C and the super-
`natant was removed. The pellet was washed once with
`pure EtOH before it was dried (as above). For 2-DE, the
`pellet was resolubilized in 100 mL of 2-D sample buffer as
`above per 100 6 106 platelets. Alternatively, the samples
`were stored in the 90% EtOH solution at 2207C until fur-
`ther use.
`
`2.4 Dialysis
`
`To reduce the salt contamination of 2-D samples from
`EtOH-precipitated platelet proteins, they were dialyzed
`against a 406 sample volume of identical 2-D sample
`buffer for 3 h at room temperature with PlusOne Mini
`Dialysis Kit (molecular mass cut-off 1 kDa) (Amersham
`Biosciences,Uppsala, Sweden).
`
`2.5 Preparation of proteins from
`nonprecipitated platelets
`
`Fifteen-hundred microliters of gel-filtered platelet (GFP)
`suspension was centrifuged at 1500 3 g for 10 min at
`room temperature. The supernatant was discarded and
`the platelet pellet was solubilized in 100 mL of 2-D sample
`buffer as above per 100 6 106 platelets.
`
`2.6 Determination of protein concentration
`
`The protein concentration in resolubilized samples was
`determined in triplicate using a CBB protein assay kit with
`BSA as the standard protein (Pierce Biotechnology,
`Rockford, IL, USA). With appropriate predilution, the 2-D
`sample buffer components do not interfere with the pro-
`tein assay. Therefore, the samples were diluted 1:20 with
`PBS and 5% of the 2-D sample buffer was added in the
`BSA standards.
`
`2.7 Analysis of platelet proteins by 1-DE and
`2-DE
`
`IEF was performed loading 120 mg (for gels to be silver-
`stained) or 150 mg (for gels with CyDye-labeled proteins)
`of platelet proteins by in-gel rehydration in a volume of
`450 mL, denaturating the 2-D buffer (7 M urea, 2 M thiou-
`rea, 4% CHAPS, 70 mM DTT, 0.5% Servalyt pH 3–10;
`
` 2005 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
`
`Serva, Heidelberg, Germany) onto 24 cm IPG DryStrips,
`pH 3–10 linear and pH 4–7 linear
`(Amersham Bio-
`sciences) and focused for 50 and 30 kVh, respectively,
`using an Amersham IPGphor unit. Before loading onto
`SDS-polyacrylamide gels, IPG strips were incubated for
`15 min in equilibration buffer (50 mM Tris-HCl, pH 8.8, 6 M
`urea, 30% glycerol, 2% SDS) containing 1% DTT and
`then for another 15 min in equilibration buffer containing
`2.5% iodoacetamide. The SDS-polyacrylamide gels
`(26 6 20 cm 6 1 mm, T = 11%, C = 2.6%) were cast
`according to Laemmli [11]. The second dimension was
`performed using an Ettan DALT six System (Amersham
`Biosciences) according to the manufacturer’s instruc-
`tions. 1-D SDS-gel electrophoresis was performed with
`13 6 16 cm gels.
`
`2.8 Protein staining and image analysis of
`silver-stained gels
`
`Silver nitrate staining for analytical gels was performed
`according to Heukeshoven and Dernick [12], while gels
`for MS analysis were stained with mass-compatible silver
`stain according to Shevchenko [13]. The silver-stained gel
`images were digitized using a Molecular Imager FX
`(BioRad). Computer-aided 2-D image analysis was car-
`ried out using the MELANIE 3 software (GeneBio, Ge-
`neva, Switzerland).
`
`2.9 Protein labeling and image analysis of DIGE
`gels
`
`Fifty micrograms of resolubilized platelet protein pre-
`parations was labeled with 333 pmol of CyDye DIGE Fluor
`minimal dyes (Amersham Biosciences). Pre-electropho-
`retic labeling was performed according to the manu-
`facturer’s instructions. The gels with separated labeled
`proteins were scanned using the Typhoon 9410 imager
`(Amersham Biosciences), and the protein patterns were
`displayed with the IQTools software. All sample gel ima-
`ges were processed by the DeCyder DIA (differential in-
`gel analysis) software (Amersham Biosciences) module to
`codetect and differentially quantify the protein spots.
`
`2.10 In-gel protein digestion
`
`The spots of interest were excised from the gels, chopped
`into pieces, and transferred into 0.5 mL tubes (Axygen,
`Union City, CA). The gel pieces were washed twice with
`200 mL of 50 mM NH4HCO3 buffer (pH 8.5) (Sigma) for
`10 min and afterwards with 200 mL of 50 mM NH4HCO3 in
`50% ACN (HPLC-grade; Merck) for 10 min. Subsequently,
`the gel pieces were dehydrated by adding 50 mL ACN and
`
`Page 3 of 9
`
`YEDA EXHIBIT NO. 2092
`MYLAN PHARM. v YEDA
`IPR2015-00644
`
`

`
`2484
`
`M. Zellner et al.
`
`Electrophoresis 2005, 26, 2481–2489
`
`in 180 mL of 10 mM DTT in 50 mM
`allowed to reswell
`NH4HCO3 buffer in order to perform reduction (567C,
`30 min). After cooling to room temperature, the solution
`was replaced by 150 mL of 50 mM iodoacetamide in
`50 mM NH4HCO3 buffer and the gel pieces were incu-
`bated in the dark for 20 min at room temperature. The gel
`pieces were washed three times with 200 mL of 50 mM
`NH4HCO3 buffer and three times with 50 mM NH4HCO3 in
`50% ACN for 10 min at room temperature, dehydrated
`with 50 mL ACN, and dried in the Eppendorf Con-
`centrator 5301 (Eppendorf, Hamburg, Germany)
`for
`5 min. The enzymatic digestion of the proteins was car-
`ried out on ice by a stepwise addition of 0.5–2 mL of
`trypsin
`(sequenzing-grade
`unmodified;
`12.5 ng/mL
`Roche, Basel, Switzerland) in 50 mM NH4HCO3 buffer until
`they were totally rehydrated. Finally, enough 50 mM
`NH4HCO3 buffer was added to keep the gel pieces cov-
`ered during digestion at 377C overnight. After digestion,
`the supernatant was removed and the peptides were
`extracted once with 20 mL 50 mM NH4HCO3 buffer and
`twice with 20 mL 5% formic acid (Sigma) by sonification
`for 5 min at room temperature in an ultrasonic water bath
`(Sonorex RK 255 H; Bandelin, Berlin, Germany).
`
`2.11 NanoHPLC-MS/MS protein sequencing
`
`All nanoHPLC separations were performed on the Ulti-
`Mate system from LC Packings (Amsterdam, The Nether-
`lands). The in-gel digests were loaded onto a precolumn
`(PepMap C18 material, 300 mm ID 6 5 mm length; LC
`Packings) by the FAMOS m-autosampler and the Switchos
`loading pump operated at 20 mL/min using water with
`0.1% TFA (Pierce, Rockford, IL, USA) as mobile phase.
`The sample was eluted from the precolumn in a back flush
`mode. The dimensions of the separation column were
`0.075 mm ID 6 150 mm length, 3 mm particle size. The
`flow rate of the nanoHPLC system was set at 200 nL/min
`and the UV detector was operated at 214 nm using the
`nano UV-Z view flow cell (volume 3 nL). The mobile phas-
`es were A = 95% water (HPLC-grade, Supra-Gradient,
`Biosolve B.V., The Netherlands), 5% ACN (HPLC-grade,
`Supra-Gradient, Biosolve B.V.), 0.1% formic acid (Fluka,
`Buchs, Switzerland); and B = 30% water, 70% ACN, 0.1%
`formic acid. The HPLC gradient for separation was 0–
`50% B in 30 min and 50–100% B in 2 min. The nanoHPLC
`system was coupled to an IT mass spectrometer (LCQ
`Deca XPplus, Thermo Finnigan) via a nanoESI source
`using Pico Tip emitters (New Objective, Cambridge, MA,
`USA). The following ESI parameters were used: spray
`voltage, 1.8 kV; capillary temperature, 1857C; capillary
`voltage, 45 V; tube lens offset voltage, 25 V; and the elec-
`tron multiplier at 21050 V. The collision energy was set
`automatically depending on the mass of the parent ion.
`
` 2005 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
`
`Gain control was set to 5 6 107. The data were collected
`in the centroid mode using Dynamic Exclusion. One MS
`experiment
`(full-MS) was followed by three MS/MS
`experiments of the three most intensive ions (intensity at
`least 1 6 106). The analysis of MS/MS spectra with
`respect to the peptide identity was routinely performed by
`applying both the MASCOT (Matrix Science) and the
`SEQUEST (Thermo Finnigan) search engines. A peptide
`was reliably identified only if the individual peptide scores
`were .43 (MASCOT) and .3.2 (SEQUEST).
`
`3 Results
`
`3.1 Sample quality of precipitated platelets and
`compatibility with 2-DE
`
`To evaluate and compare the applicability of TCA precip-
`itation and EtOH precipitation for clinical proteomics, we
`used these methods for the preparation of proteins from
`blood platelets for 2-DE. GFP showed a mean con-
`centration of 117 6 42 6 106 Plt/mL. This suspension
`was subjected to a precipitation either with TCA or with
`EtOH, according to the procedures described in Sec-
`tion 2. The 2-D gel of TCA-precipitated proteins showed a
`clear protein pattern with about 1400 individual spots,
`which were found with good reproducibility (Fig. 1A).
`However, EtOH-precipitated proteins were only well
`separated in the lower pI range (Fig. 1B). In the pI range
`above 6.0, the proteins were only seen as horizontal
`streaks. This indicates a nonsufficient separation of
`EtOH-precipitated proteins in the first-dimensional IEF.
`Figures 1D–F show the electrical current and the voltage
`profile of the IEF separation. The high current peak in the
`first part of the IEF of EtOH-precipitated proteins indi-
`cates that this sample contained high salt concentrations
`(Fig. 1E, arrow). These salts had to be removed by dialysis
`in order to get a satisfactory separation by 2-DE (Fig. 1C
`and F). This dialysis step was included later on in all fol-
`lowing EtOH-precipitation experiments.
`
`3.2 Protein yield
`
`The protein precipitation methods were evaluated in the
`GFP preparations of 60 different volunteers. The amount
`of proteins, which was extracted from 100 6 106 platelets
`after TCA precipitation, was equal to that extractable after
`EtOH precipitation from the same number of platelets
`(Fig. 2A). The protein amount increased linearly with the
`number of platelets used in the experiments (Fig. 2B). As
`an alternative approach for increasing the platelet con-
`centration of GFP, we centrifuged the cell suspension and
`extracted the proteins from the pellet in the 2-D sample
`
`Page 4 of 9
`
`YEDA EXHIBIT NO. 2092
`MYLAN PHARM. v YEDA
`IPR2015-00644
`
`

`
`Electrophoresis 2005, 26, 2481–2489
`
`Validation of different protein precipitation methods
`
`2485
`
`Figure 1. 2-D electrophoretic analysis of gel-filtered human platelet suspension following precipitation with (A) TCA and
`(B) EtOH resolubilized in 2-D sample buffer. In (C) EtOH-precipitated and -solubilized platelet proteins were dialyzed
`against fresh 2-D sample buffer to remove salt contamination. Twelve-hundred microliters of prepared platelet proteins was
`loaded by passive rehydration onto 24 cm pH 3–10 IPG strips. Current and voltage profile were recorded of (D) TCA-,
`(E) EtOH-, and (F) EtOH-precipitated and -dialyzed platelet samples during the 1-D. Gels were stained with analytical silver
`nitrate stain.
`
`buffer. The supernatant contained almost no protein (2 mg
`proteins per 100 6 106 platelets). The amount of proteins
`extracted from these nonprecipitated platelets was simi-
`lar to that found after precipitation (124 6 10 mg proteins
`per 100 6 106 platelets). These data show that both pre-
`cipitation methods have a similar protein yield and indi-
`cate that precipitation followed by resolubilization is not
`accompanied by a major protein loss.
`
`3.3 Specificity of protein precipitation
`
`To characterize potential protein specific differences in
`precipitation efficiency, we performed a comparative
`electrophoretic analysis. Nonprecipitated, TCA-pre-
`cipitated, and EtOH-precipitated platelet proteins were
`separated in 1-D SDS-PAGE. The results are shown in
`Fig. 3A. The protein band pattern is similar in all three
`samples. Only the nonprecipitated platelets show some
`slight bands in the upper molecular weight range, which
`
` 2005 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
`
`are barely detectable in the precipitated samples. TCA-
`and EtOH-precipitated proteins showed a nearly identical
`pattern of protein bands.
`
`For definitive comparison of different precipitation meth-
`ods on platelet protein pattern, we switched to the differ-
`ential gel electrophoresis (DIGE) technology. TCA-pre-
`cipitated proteins, EtOH-precipitated proteins, and non-
`precipitated proteins were labeled with three different
`fluorescent dyes, combined and separated by 2-DE. The
`overlay of the three signals is shown in Fig. 3B. Most pro-
`tein spots are equally present in all three samples (black
`spots). However, some protein spots which are present in
`the nonprecipitated samples are diminished in the TCA-
`precipitated and EtOH-precipitated samples (magenta
`spots). These proteins are equally distributed all over the
`2-D gel. Almost no TCA-specific protein spots (blue) or
`EtOH-specific protein spots (yellow) are visible. However,
`some green protein spots are present in the 2-D gel, indi-
`cating proteins which are enriched by both precipitation
`
`Page 5 of 9
`
`YEDA EXHIBIT NO. 2092
`MYLAN PHARM. v YEDA
`IPR2015-00644
`
`

`
`2486
`
`M. Zellner et al.
`
`Electrophoresis 2005, 26, 2481–2489
`
`the nonprecipitated sample
`cipitated sample against
`(Figs. 3C and D) and of the EtOH-precipitated sample
`against
`the TCA-precipitated sample (Fig. 3E). About
`75% of all protein spots are present at the same levels in
`the EtOH-precipitated samples and nonprecipitated
`samples, whereas 11.6% are over-represented in the
`EtOH samples and 13.5% in nonprecipitated samples
`(Fig. 3C). Similarly, 79% are present at the same level in
`the TCA-precipitated samples and nonprecipitated sam-
`ples (Fig. 3D). However, when comparing the EtOH-pre-
`cipitated samples with the TCA-precipitated samples,
`91% of all protein spots turned out to be equally present
`in both samples (Fig. 3E). This scatter graph shows a
`substantially narrower Gaussian distribution of the protein
`spots than the other two graphs. This indicates a much
`stronger similarity between the two precipitation methods
`than between one single precipitation method and the
`nonprecipitated samples. Almost all of the 8.7% over-
`represented in TCA samples were overlapping spots
`within the two spikes left and right of the b-actin spots
`(chains of light blue spots indicated by arrows in Fig. 3B).
`Since b-actin was found in the whole spike, it could not be
`determined whether this overrepresentation is derived
`from other proteins or is a b-actin effect.
`
`4 Discussion
`
`The present study evaluates the usability of two different
`protein precipitation methods, the EtOH precipitation and
`TCA precipitation, for the proteomic analysis of human
`platelets. It characterizes the precipitation efficiency on
`an overall as well as on a protein-specific level.
`
`Due to the distinct chemistry of EtOH and TCA, the pro-
`tein samples are treated in a different way for precipita-
`tion. For EtOH precipitation, platelets were diluted in a
`9-fold volume of EtOH and then incubated at room tem-
`perature. Studies with the human plasma showed that
`most proteins precipitate already at an EtOH concentra-
`tion of 40% v/v [5]. However, there were still some soluble
`proteins found under such conditions. The high surplus of
`EtOH used in our study facilitates the precipitation of all
`proteins. EtOH is readily miscible with water, but yields a
`significant heat of solution and has the tendency to
`denature proteins, especially at temperature above 07C
`[6]. In protein fractionation experiments, which are aiming
`at preparing nondenatured proteins, normally a “cold
`EtOH precipitation” protocol is used, in which the solvent
`temperature is always kept below 07C. In proteomics,
`however, denaturation is unproblematic as far as it is not
`accompanied by protein modification. It is, therefore, not
`necessary to decrease the temperature during EtOH pre-
`cipitation. In addition, EtOH has a lower dielectric con-
`
`Figure 2. Platelet protein yield for each precipitation
`method.
`(A) GFP preparations of different volunteers
`(n = 18) were precipitated with TCA as well as with EtOH
`and resolubilized in 2-D sample buffer (70 mL/100 6 106
`platelets for TCA and 100 mL/100 6 106 platelets for
`EtOH precipitation). EtOH-precipitated samples were
`dialyzed. Protein concentration was determined by Brad-
`ford. Values are expressed as mean value 6 SD. (B) Plate-
`let protein yield for each precipitation method of differ-
`ently concentrated GFP suspensions. GFP preparations
`of different volunteers were precipitated with TCA (n = 51
`volunteers; closed circle) or with EtOH (n = 18 volunteers;
`open triangle). Linear regression was calculated for pro-
`tein yield of differently concentrated GFP suspensions
`precipitated by TCA or EtOH.
`
`methods. Proteins which showed a modified abundance
`in precipitated samples in at
`least
`two independent
`experiments are indicated in Fig. 3B and their identity is
`shown in Table 1.
`
`To quantify the protein-specific properties of the three
`extraction methods a scatter plot analysis was per-
`formed. Therefore, we plotted the fluorescence intensity
`signal of every single spot of the EtOH- or TCA-pre-
`
` 2005 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
`
`Page 6 of 9
`
`YEDA EXHIBIT NO. 2092
`MYLAN PHARM. v YEDA
`IPR2015-00644
`
`

`
`Electrophoresis 2005, 26, 2481–2489
`
`Validation of different protein precipitation methods
`
`2487
`
`Figure 3. 1-D and 2-D DIGE-analysis of nonprecipitated, TCA- and EtOH-precipitated platelet samples. (A) Silver-stained
`1-D gel with 2 mg protein from each platelet preparation. (B) 2-D fluorescence overlay image of 50 mg protein from each
`simultaneously made platelet preparation are focused in one IPG strip (pH 4–7). TCA-precipitated platelet proteins are
`shown in blue, EtOH-precipitated platelet proteins in yellow, and nonprecipitated platelet proteins in magenta. Proteins
`which are equally present in each platelet protein preparation are displayed in black. The figure shows one of two inde-
`pendent experiments. (C–E) Scatter plot analysis of the 2-D gel shown in (B). Each dot represents one protein spot. Its
`position indicates the fluorescence intensity signal in the respective preparation group. Analysis includes 829 spots, which
`were detected in all preparation groups in two independent experiments. Regression line and confidential intervals indi-
`cating the twofold SD are shown. R indicates the linear correlation coefficient. (C) Nonprecipitated versus EtOH-pre-
`cipitated samples; R = 0.988, (D) nonprecipitated versus TCA-precipitated samples; R = 0.975, (E) EtOH-precipitated
`versus TCA-precipitated samples; R = 0.979.
`
` 2005 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
`
`Page 7 of 9
`
`YEDA EXHIBIT NO. 2092
`MYLAN PHARM. v YEDA
`IPR2015-00644
`
`

`
`2488
`
`M. Zellner et al.
`
`Electrophoresis 2005, 26, 2481–2489
`
`Table 1. Identifications of representative precipitation-
`dependent and -independent proteins
`
`Spot
`ID
`
`Protein name
`
`Accession
`number
`
`Protein spots decreased in TCA- and EtOH-precipitated
`platelet samples
`A1
`Transgelin 2 isoform
`A2
`Transgelin 2 isoform
`TM3a) chain isoform
`C1
`C2
`Myosin heavy chain b-subunit
`D
`TM3, fibroblast
`E1
`Vinculin isoform
`E2
`Vinculin isoform
`F
`Nucleosome assembly protein
`1-like 1
`
`Q9BUH5
`Q9BUH5
`P06753
`Q14905
`NCBI 88928
`P18206
`P18206
`P55209
`
`Protein spots increased in TCA and EtOH-precipitated
`platelet samples
`B
`TM3 chain isoform
`G
`PDZ and LIM domain
`
`P06753
`O00151
`
`Protein spots equally present in all platelet samples
`H
`P02672
`Fibrinogen g chain A
`I
`Heat shock cognate 71 kDa
`P11142
`protein
`Chloride channel
`Integrin a IIb isoform
`Albumin
`TM3 chain isoform
`
`O00299
`P08514
`P02768
`P06753
`
`J
`K
`L
`M
`
`a) Tropomyosin a 3
`
`stant at room temperature than below 07C, which further
`facilitates the precipitation [9]. The platelets used in this
`study were suspended in a buffered isotonic salt solution
`in order to avoid hypotonic lysis. Due to the low solubility
`of salts in alcohols, EtOH precipitation is not suitable to
`remove salts from the platelet sample, which resulted in
`an insufficient protein separation in the IEF. This effect
`was also observed when the precipitation was performed
`at 2207C (data not shown). To reduce the salt concentra-
`tion, the resolubilized precipitate had to be dialyzed which
`is a time and cost intensive extension of the EtOH-pre-
`cipitation protocol. However, the quantitative validation of
`the EtOH-precipitated and dialyzed samples indicate that
`dialysis has almost no effects on the protein composition
`of the sample.
`
`For TCA precipitation, the precipitant was added to the
`platelet suspension to a final concentration of 25%. The
`TCA-induced protein precipitation curves are observed to
`be U-shaped [10]. All proteins are soluble at very low TCA
`concentrations and the first precipitation of serum albu-
`min can be observed when the concentration increases
`
` 2005 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
`
`above 5%. Between 15 and 40% TCA even the highly
`TCA-soluble protein cardiotoxin III precipitates. When the
`acid concentrations are raised above 50%, all proteins
`are found to redissolve back into the solution. This is
`thought to be mediated by acid-induced structural tran-
`sitions in the proteins. Such irreversible protein modifica-
`tion should be avoided in the preparation of samples for
`proteome analysis. Thus, the TCA concentration used in
`the present study is suited to precipitate almost all pro-
`teins with a minimum of protein modification. In order to
`avoid any acid-induced protein hydrolysis during storage,
`the precipitate is centrifuged and washed in acetone to
`remove TCA. The organic solvent, acetone, is on one
`hand, a protein precipitant with a similar dielectric con-
`stant as EtOH, and on the other hand, a good solvent of
`TCA.
`
`The present study shows that, in spite of the different
`chemistries and the different precipitation protocols,
`EtOH and TCA precipitation lead to similar results in the
`proteomic analysis. Both the methods seem to induce
`precipitation of almost all proteins of the platelet suspen-
`sion. The incubation of the precipitated proteins in the
`strongly denaturing 2-D buffer, which contained chao-
`tropic agents and detergents, resolubilized almost all
`proteins. The protein content of this solution was inde-
`pendent of the used precipitant. The amount of protein
`found after precipitation and resolubilization was the
`same as in a 2-D buffer extract from the same number
`of platelets, which were concentrated by centrifugation
`instead of precipitat

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket